ABBV-189

N/A

Report date: 2026/03/19 16:57:36

Base Information

Drug NameABBV-189

Drug Alias Nameanti-CD3/anti-survivin/anti-albumin trispecific T-cell engager (AbbVie/Harpoon)ABBV-189

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsBaculoviral IAP repeat-containing protein 5 modulatorsSerum albumin modulators

TargetsSerum albuminT cell surface glycoprotein CD3Baculoviral IAP repeat-containing protein 5

Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAbbvie Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAbbvie Inc

Active IndicationsN/A

Inactive IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A